Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many people (1) were offered, (2) attended, and (3) completed, structured diabetes education courses over 12 months after being diagnosed with (a) Type 1, and (a) Type 2, diabetes; and what steps they are taking to increase referrals in groups other than those newly diagnosed with diabetes.
Answered by Baroness Blackwood of North Oxford
The National Diabetes Audit (NDA) reports on the number of people who are offered and attended structured education programmes within 12 months of diabetes diagnosis. Data on the completion of structured education is not available within the NDA.
The number of people who were offered and attended structured education within 12 months of being diagnosed with diabetes in 2016, by diabetes type in England can be found in the following table.
Diabetes type | Newly diagnosed with diabetes in 2016 | Offered structured education within 12 months of diagnosis | Attended structured education within 12 months of diagnosis |
Type 1 | 8,975 | 3,460 | 405 |
Type 2 and other | 207,630 | 155,980 | 18,045 |
Notes:
NHS England are working to reduce inequalities and widen routes of access to structured education by offering digital self-management support programmes which can offer a more flexible option, particularly for those of working age. These include:
- Access to Healthy Living for People with type 2 Diabetes (HeLP Diabetes) which is an evidenced online self-management tool for those with type 2 diabetes. This will be centrally funded, by NHS England and made available nationally, with implementation starting later this year. The intention is for HeLP Diabetes to be offered to both the newly-diagnosed and prevalent populations, supporting those living with type 2 diabetes at the point of diagnosis and on an ongoing basis;
- NHS England has made £2 million available through the NHS Test Bed Programme to implement and evaluate digital delivery models for self-management education for people living with type 2 diabetes; and
- Clinical commissioning groups who are in receipt of transformation funding have been supported by NHS England to increase uptake of structured education by use of funding to commission digital services where it has been agreed that this would best meet the needs of the local population.
Further to the commitments in the NHS Long Term Plan, the National Implementation Framework, is to be published in the spring, which will provide further information on how the NHS Long Term Plan will be implemented. This will set out further detail on how the National Health Service will further expand provision of structured education and the pace at which local systems will widen provision and routes of access.
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 March (HL14049), whether they will now answer the question put, namely what the annual cost of prescribing methadone in England was in each of the last five years.
Answered by Baroness Blackwood of North Oxford
The full data requested is not collected centrally or by NHS England. The data is partially held by either NHS Digital or the NHS Business Services Authority.
As part of its formal framework agreement with the Department, NHS Digital collects, processes and publishes data from across the health and social care system in England, including data on prescribing and medicines. NHS Digital reports that it does not hold the prescription level data requested but does hold data on the net ingredient cost of Methadone Hydrochloride prescription items written in the United Kingdom and dispensed in the community in England, via an FP10 prescription form. This is provided in the following table. Data is not available broken down into the cost of ordering, storage, transport, security, administration and prescription costs.
Data on local methadone prescribing and supply may be held by individual National Health Service bodies, for example, clinical commissioning groups or NHS trusts.
British National Formulary (BNF) Chemical Name | BNF 3.9.1 Cough Suppressants | BNF 4.7.2 Opioid Analgesic | BNF 4.10.3 Opioid Dependence | Total Net Ingredient Cost | |
2013 | Methadone Hydrochloride | £1,025 | £986,129 | £20,139,545 | £21,126,699 |
2014 | Methadone Hydrochloride | £1,692 | £964,223 | £18,852,099 | £19,818,014 |
2015 | Methadone Hydrochloride | £1,586 | £858,415 | £18,456,074 | £19,316,075 |
2016 | Methadone Hydrochloride | £362 | £596,809 | £17,054,254 | £17,651,425 |
2017 | Methadone Hydrochloride | £590 | £517,711 | £15,252,240 | £15,770,541 |
Source: Prescription Cost Analysis, NHS Digital
Notes:
The NHS Business Services Authority is a special health authority and arm’s length body of the Department and processes 1 billion prescription items for pharmacists who have dispensed prescriptions in England. The NHS Business Services Authority has provided data of remuneration costs from 2014 to 2018, for English pharmacies only, for the dispensing of methadone. This is provided in the following table.
Calendar Year | Remuneration for Methadone (£) |
2014 | 41,556,608.82 |
2015 | 41,647,409.24 |
2016 | 41,720,280.70 |
2017 | 45,319,400.63 |
2018 | 45,932,852.74 |
Source: NHS Business Services Authority Information Services Data Warehouse
Notes:
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 March (HL14049), what costs are associated with the NHS prescribing methadone in England; and which public bodies, if any, collate data in relation such costs.
Answered by Baroness Blackwood of North Oxford
The full data requested is not collected centrally or by NHS England. The data is partially held by either NHS Digital or the NHS Business Services Authority.
As part of its formal framework agreement with the Department, NHS Digital collects, processes and publishes data from across the health and social care system in England, including data on prescribing and medicines. NHS Digital reports that it does not hold the prescription level data requested but does hold data on the net ingredient cost of Methadone Hydrochloride prescription items written in the United Kingdom and dispensed in the community in England, via an FP10 prescription form. This is provided in the following table. Data is not available broken down into the cost of ordering, storage, transport, security, administration and prescription costs.
Data on local methadone prescribing and supply may be held by individual National Health Service bodies, for example, clinical commissioning groups or NHS trusts.
British National Formulary (BNF) Chemical Name | BNF 3.9.1 Cough Suppressants | BNF 4.7.2 Opioid Analgesic | BNF 4.10.3 Opioid Dependence | Total Net Ingredient Cost | |
2013 | Methadone Hydrochloride | £1,025 | £986,129 | £20,139,545 | £21,126,699 |
2014 | Methadone Hydrochloride | £1,692 | £964,223 | £18,852,099 | £19,818,014 |
2015 | Methadone Hydrochloride | £1,586 | £858,415 | £18,456,074 | £19,316,075 |
2016 | Methadone Hydrochloride | £362 | £596,809 | £17,054,254 | £17,651,425 |
2017 | Methadone Hydrochloride | £590 | £517,711 | £15,252,240 | £15,770,541 |
Source: Prescription Cost Analysis, NHS Digital
Notes:
The NHS Business Services Authority is a special health authority and arm’s length body of the Department and processes 1 billion prescription items for pharmacists who have dispensed prescriptions in England. The NHS Business Services Authority has provided data of remuneration costs from 2014 to 2018, for English pharmacies only, for the dispensing of methadone. This is provided in the following table.
Calendar Year | Remuneration for Methadone (£) |
2014 | 41,556,608.82 |
2015 | 41,647,409.24 |
2016 | 41,720,280.70 |
2017 | 45,319,400.63 |
2018 | 45,932,852.74 |
Source: NHS Business Services Authority Information Services Data Warehouse
Notes:
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 March (HL14049), what data they hold on the annual cost of prescribing methadone on the NHS in England.
Answered by Baroness Blackwood of North Oxford
The full data requested is not collected centrally or by NHS England. The data is partially held by either NHS Digital or the NHS Business Services Authority.
As part of its formal framework agreement with the Department, NHS Digital collects, processes and publishes data from across the health and social care system in England, including data on prescribing and medicines. NHS Digital reports that it does not hold the prescription level data requested but does hold data on the net ingredient cost of Methadone Hydrochloride prescription items written in the United Kingdom and dispensed in the community in England, via an FP10 prescription form. This is provided in the following table. Data is not available broken down into the cost of ordering, storage, transport, security, administration and prescription costs.
Data on local methadone prescribing and supply may be held by individual National Health Service bodies, for example, clinical commissioning groups or NHS trusts.
British National Formulary (BNF) Chemical Name | BNF 3.9.1 Cough Suppressants | BNF 4.7.2 Opioid Analgesic | BNF 4.10.3 Opioid Dependence | Total Net Ingredient Cost | |
2013 | Methadone Hydrochloride | £1,025 | £986,129 | £20,139,545 | £21,126,699 |
2014 | Methadone Hydrochloride | £1,692 | £964,223 | £18,852,099 | £19,818,014 |
2015 | Methadone Hydrochloride | £1,586 | £858,415 | £18,456,074 | £19,316,075 |
2016 | Methadone Hydrochloride | £362 | £596,809 | £17,054,254 | £17,651,425 |
2017 | Methadone Hydrochloride | £590 | £517,711 | £15,252,240 | £15,770,541 |
Source: Prescription Cost Analysis, NHS Digital
Notes:
The NHS Business Services Authority is a special health authority and arm’s length body of the Department and processes 1 billion prescription items for pharmacists who have dispensed prescriptions in England. The NHS Business Services Authority has provided data of remuneration costs from 2014 to 2018, for English pharmacies only, for the dispensing of methadone. This is provided in the following table.
Calendar Year | Remuneration for Methadone (£) |
2014 | 41,556,608.82 |
2015 | 41,647,409.24 |
2016 | 41,720,280.70 |
2017 | 45,319,400.63 |
2018 | 45,932,852.74 |
Source: NHS Business Services Authority Information Services Data Warehouse
Notes:
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 March (HL14049), how much NHS England spent on prescribing methadone in each of the last five years.
Answered by Baroness Blackwood of North Oxford
The full data requested is not collected centrally or by NHS England. The data is partially held by either NHS Digital or the NHS Business Services Authority.
As part of its formal framework agreement with the Department, NHS Digital collects, processes and publishes data from across the health and social care system in England, including data on prescribing and medicines. NHS Digital reports that it does not hold the prescription level data requested but does hold data on the net ingredient cost of Methadone Hydrochloride prescription items written in the United Kingdom and dispensed in the community in England, via an FP10 prescription form. This is provided in the following table. Data is not available broken down into the cost of ordering, storage, transport, security, administration and prescription costs.
Data on local methadone prescribing and supply may be held by individual National Health Service bodies, for example, clinical commissioning groups or NHS trusts.
British National Formulary (BNF) Chemical Name | BNF 3.9.1 Cough Suppressants | BNF 4.7.2 Opioid Analgesic | BNF 4.10.3 Opioid Dependence | Total Net Ingredient Cost | |
2013 | Methadone Hydrochloride | £1,025 | £986,129 | £20,139,545 | £21,126,699 |
2014 | Methadone Hydrochloride | £1,692 | £964,223 | £18,852,099 | £19,818,014 |
2015 | Methadone Hydrochloride | £1,586 | £858,415 | £18,456,074 | £19,316,075 |
2016 | Methadone Hydrochloride | £362 | £596,809 | £17,054,254 | £17,651,425 |
2017 | Methadone Hydrochloride | £590 | £517,711 | £15,252,240 | £15,770,541 |
Source: Prescription Cost Analysis, NHS Digital
Notes:
The NHS Business Services Authority is a special health authority and arm’s length body of the Department and processes 1 billion prescription items for pharmacists who have dispensed prescriptions in England. The NHS Business Services Authority has provided data of remuneration costs from 2014 to 2018, for English pharmacies only, for the dispensing of methadone. This is provided in the following table.
Calendar Year | Remuneration for Methadone (£) |
2014 | 41,556,608.82 |
2015 | 41,647,409.24 |
2016 | 41,720,280.70 |
2017 | 45,319,400.63 |
2018 | 45,932,852.74 |
Source: NHS Business Services Authority Information Services Data Warehouse
Notes:
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 March (HL14049), what was the annual cost to the NHS of providing methadone in England in each of the last five years, broken down by (1) ordering, (2) storage, (3) transport, (4) security, (5) administration, (6) prescription, and (7) dispensing costs.
Answered by Baroness Blackwood of North Oxford
The full data requested is not collected centrally or by NHS England. The data is partially held by either NHS Digital or the NHS Business Services Authority.
As part of its formal framework agreement with the Department, NHS Digital collects, processes and publishes data from across the health and social care system in England, including data on prescribing and medicines. NHS Digital reports that it does not hold the prescription level data requested but does hold data on the net ingredient cost of Methadone Hydrochloride prescription items written in the United Kingdom and dispensed in the community in England, via an FP10 prescription form. This is provided in the following table. Data is not available broken down into the cost of ordering, storage, transport, security, administration and prescription costs.
Data on local methadone prescribing and supply may be held by individual National Health Service bodies, for example, clinical commissioning groups or NHS trusts.
British National Formulary (BNF) Chemical Name | BNF 3.9.1 Cough Suppressants | BNF 4.7.2 Opioid Analgesic | BNF 4.10.3 Opioid Dependence | Total Net Ingredient Cost | |
2013 | Methadone Hydrochloride | £1,025 | £986,129 | £20,139,545 | £21,126,699 |
2014 | Methadone Hydrochloride | £1,692 | £964,223 | £18,852,099 | £19,818,014 |
2015 | Methadone Hydrochloride | £1,586 | £858,415 | £18,456,074 | £19,316,075 |
2016 | Methadone Hydrochloride | £362 | £596,809 | £17,054,254 | £17,651,425 |
2017 | Methadone Hydrochloride | £590 | £517,711 | £15,252,240 | £15,770,541 |
Source: Prescription Cost Analysis, NHS Digital
Notes:
The NHS Business Services Authority is a special health authority and arm’s length body of the Department and processes 1 billion prescription items for pharmacists who have dispensed prescriptions in England. The NHS Business Services Authority has provided data of remuneration costs from 2014 to 2018, for English pharmacies only, for the dispensing of methadone. This is provided in the following table.
Calendar Year | Remuneration for Methadone (£) |
2014 | 41,556,608.82 |
2015 | 41,647,409.24 |
2016 | 41,720,280.70 |
2017 | 45,319,400.63 |
2018 | 45,932,852.74 |
Source: NHS Business Services Authority Information Services Data Warehouse
Notes:
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 March (HL14049), whether any public body other than NHS Digital holds the necessary prescription level data to provide the annual cost of prescribing methadone in England for each of the last five years; and if not, why not.
Answered by Baroness Blackwood of North Oxford
The full data requested is not collected centrally or by NHS England. The data is partially held by either NHS Digital or the NHS Business Services Authority.
As part of its formal framework agreement with the Department, NHS Digital collects, processes and publishes data from across the health and social care system in England, including data on prescribing and medicines. NHS Digital reports that it does not hold the prescription level data requested but does hold data on the net ingredient cost of Methadone Hydrochloride prescription items written in the United Kingdom and dispensed in the community in England, via an FP10 prescription form. This is provided in the following table. Data is not available broken down into the cost of ordering, storage, transport, security, administration and prescription costs.
Data on local methadone prescribing and supply may be held by individual National Health Service bodies, for example, clinical commissioning groups or NHS trusts.
British National Formulary (BNF) Chemical Name | BNF 3.9.1 Cough Suppressants | BNF 4.7.2 Opioid Analgesic | BNF 4.10.3 Opioid Dependence | Total Net Ingredient Cost | |
2013 | Methadone Hydrochloride | £1,025 | £986,129 | £20,139,545 | £21,126,699 |
2014 | Methadone Hydrochloride | £1,692 | £964,223 | £18,852,099 | £19,818,014 |
2015 | Methadone Hydrochloride | £1,586 | £858,415 | £18,456,074 | £19,316,075 |
2016 | Methadone Hydrochloride | £362 | £596,809 | £17,054,254 | £17,651,425 |
2017 | Methadone Hydrochloride | £590 | £517,711 | £15,252,240 | £15,770,541 |
Source: Prescription Cost Analysis, NHS Digital
Notes:
The NHS Business Services Authority is a special health authority and arm’s length body of the Department and processes 1 billion prescription items for pharmacists who have dispensed prescriptions in England. The NHS Business Services Authority has provided data of remuneration costs from 2014 to 2018, for English pharmacies only, for the dispensing of methadone. This is provided in the following table.
Calendar Year | Remuneration for Methadone (£) |
2014 | 41,556,608.82 |
2015 | 41,647,409.24 |
2016 | 41,720,280.70 |
2017 | 45,319,400.63 |
2018 | 45,932,852.74 |
Source: NHS Business Services Authority Information Services Data Warehouse
Notes:
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what the annual cost of prescribing methadone in England was for each of the last five years.
Answered by Baroness Blackwood of North Oxford
NHS Digital does not hold the prescription level data requested.
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what support and assistance they plan to offer obese people with a body mass index of 30 and above who have not been diagnosed with Type 2 diabetes or hypertension.
Answered by Baroness Blackwood of North Oxford
Public Health England (PHE) has a responsibility to support the local delivery of evidence-based, effective and sustainable weight management services, as recommended by the National Institute for Health and Care Excellence (NICE), which support adults who are obese (that is, with a body mass index over 30 kg/m2, or lower for those from black and minority ethnic groups) or with other risk factors.
PHE provides practitioners, commissioners and providers of tier 2 weight management services with a range of resources to support the commissioning and delivery of these services. This includes:
- Guidance on how services should include diet, physical activity, and behaviour change components; and
- A tool to support the implementation of evidence-based behaviour change techniques.
A copy of this tool, Changing Behaviour: Techniques for Tier 2 Adult Weight Management Services, is attached.
NICE has also produced a guideline, Weight management: lifestyle services for overweight or obese adults, aimed at commissioners, health professionals, providers of lifestyle weight management programmes, adults who are overweight or obese, their families and other members of the public. This guideline covers lifestyle weight management services including programmes, courses, clubs or groups provided by the public, private and voluntary sector. The aim is to help people lose weight and become more physically active to reduce the risk of diseases associated with obesity. A copy of NICE’s guideline is attached.
Asked by: Lord Brooke of Alverthorpe (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government when, under the NHS Long Term Plan, they will offer support and access to weight management services in primary care for people with a diagnosis of Type 2 diabetes or hypertension with a body mass index of 30 and above; what will be the nature of any such services; and who will provide those services.
Answered by Baroness Blackwood of North Oxford
The NHS Long Term Plan builds on the success of the NHS Diabetes Prevention Programme and diabetes treatment services and will provide a targeted support offer to patients with both obesity and type 2 diabetes, or with obesity and hypertension. The services will be provided in local communities and an implementation plan is currently under development.
NHS England plans to increase access to services in secondary care for those with severe obesity. This will include the testing of very low calorie diets.
NHS England, with its partners working in public health and diabetes, will help to ensure nutrition has a greater place in professional education. This will ensure that clinical staff have the skills and confidence to support patients in achieving and maintaining a healthy weight.